The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1261 articles
Employers are grappling with the rising costs of GLP-1 agonists like Ozempic and Wegovy for weight loss. A new KFF analysis reveals potential shifts in coverage as companies weigh the benefits against financial burdens. Discover strategies for navigating this evolving landscape and prioritizing metabolic health.
Recent leadership changes at Novo Nordisk, the pharmaceutical giant behind Ozempic and Wegovy, have sparked discussions about the future of GLP-1 innovation and the company's direction. What does this mean for the future of weight loss drugs and metabolic health?
Peptide patches are emerging as a convenient, needle-free alternative to traditional peptide injections. Learn how this innovative delivery system could revolutionize the way we approach recovery, immune support, and overall wellness.
Novo Nordisk, the maker of Wegovy, is experiencing significant boardroom changes. This shakeup raises questions about the future of Wegovy, GLP-1 therapies, and the broader weight loss landscape. Let's delve into what this means for consumers and the future of metabolic health.
Jelly Roll's dramatic weight loss transformation is inspiring fans worldwide. Learn how he achieved it through diet and exercise, his motivations, and the challenges he faced along the way.
Emerging research highlights the potential of alpha-ketoglutarate (AKG) in addressing insulin resistance and improving metabolic health. This blog post explores the science behind AKG and its potential benefits for longevity and overall wellness.
Researchers at Nagaland University have identified Sinapic acid, a naturally occurring plant compound, as a potential therapeutic agent for diabetic wound healing. This discovery could lead to more effective and accessible treatments for diabetic foot ulcers.
Recent research highlights the critical link between sleep deprivation and gut health. Sleep loss can disrupt your gut microbiome, leading to decreased levels of essential metabolites like taurine. Understanding this connection is vital for overall wellness.
Weight loss medications, particularly GLP-1 receptor agonists, are influencing consumer behavior in unexpected ways. A recent study reveals shifts in grocery spending, dining habits, and even vacation choices among users.
